HealthCare Research Reports
rootsanalysis.com

The Drug Repurposing Service Providers Market is estimated to be worth USD 1.2 billion in 2030, predicts Roots Analysis
Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs
rootsanalysis.com

Roots Analysis offers market research reports highlighting insightful opinions within the pharma, biotech and medical devices industry. With over 500 clients spread across the small pharma, large pharma, VC firms and academic institutes, our intellectual capital encompasses very niche / emerging market segments